Table 1.
Clinical characteristics during disease course
| Days after LT | 50 | 80 | 87 | 104 | 111 | 118 |
| Clinical course | Current admission | Before defibrotide | After defibrotide/TAC withdrawal | Resolution | ||
| ALT (U/L) | 17 | 35 | 39 | 43 | 26 | 23 |
| TB (μmol/L) | 16 | 20 | 57 | 76 | 42 | 13 |
| Platelet (109/mL) | 156 | 171 | 183 | 175 | 158 | 173 |
| PT (s) | 11.5 | 11.3 | 12.5 | 12.7 | 11.5 | 12.2 |
| D-dimer (mg/L) | 0.27 | 0.34 | 0.52 | 0.41 | 0.32 | 0.33 |
| TAC (ng/mL) | 7.9 | 8.9 | 7.2 | 5.6 | ||
| CSA (ng/mL) | 126 | 165 | ||||
| Wt (kg) | 64.5 | 66.0 | 67.9 | 69.5 | 67.5 | 64.8 |
LT: Liver transplantation; ALT: Alanine aminotransferase; TB: Total bilirubin; PT: Prothrombin time; TAC: Tacrolimus; CSA: Cyclosporine A; Wt: Body weight.